Galena Biopharma to Present at the 25th Annual ROTH Conference

Galena Biopharma to Present at the 25th Annual ROTH Conference

LAKE OSWEGO, Ore., March 11, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biopharmaceutical company that develops innovative, targeted
oncology treatments that address major unmet medical needs to advance cancer
care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive
Officer, will present a corporate update at the 25^th Annual ROTH Conference.
The presentation will take place on Monday, March 18, 2013 at 12:00 p.m. PDT.

The presentation will be webcast and available on the Investors section of the
Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company that develops innovative, targeted oncology
treatments that address major unmet medical needs to advance cancer care.For
more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10647

CONTACT: Madeline Hatton
         Toll free: +1 (855) 855-GALE (4253), ext. 109
         info@galenabiopharma.com
        
         or
        
         Remy Bernarda
         IR Sense, LLC
         +1 (503) 400-6995
         remy@irsense.com

Galena Biopharma, Inc.